| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 3,417 | 7,239 | ||
| Investment, related party | 10 | 9 | ||
| Accounts receivable, net | 2,995 | 3,955 | ||
| Inventories, net | 4,329 | 4,028 | ||
| Prepaid expenses and other current assets | 629 | 331 | ||
| Asset held for sale | 2,300 | 2,300 | ||
| Other assets, related party-Related Party | 733 | 953 | ||
| Total current assets | 14,413 | 18,815 | ||
| Property and equipment, net | 20 | 37 | ||
| Operating lease right-of-use assets | 488 | 729 | ||
| Intangible assets, net | 22 | 26 | ||
| Other assets | 472 | 535 | ||
| Total assets | 15,415 | 20,142 | ||
| Accounts payable, related parties, net-Nonrelated Party | 3,639 | 4,268 | ||
| Accounts payable, related parties, net-Related Party | 2,054 | 670 | ||
| Accrued expenses and other current liabilities | 6,553 | 5,806 | ||
| Advance from stockholders | - | 8,500 | ||
| Operating lease liabilities | 307 | 443 | ||
| Total current liabilities | 12,553 | 19,687 | ||
| Convertible notes payable, net | 4,462 | 4,338 | ||
| Warrant liabilities | 833 | 548 | ||
| Other liabilities | 12 | 14 | ||
| Operating lease liabilities, non-current | 136 | 223 | ||
| Total liabilities | 17,996 | 24,810 | ||
| Preferred stock | 0 | - | ||
| Preferred stock-Series B2Preferred Stock | 0 | - | ||
| Preferred stock-Series B3Preferred Stock | 0 | - | ||
| Preferred stock-Series CConvertible Preferred Stock | 0 | - | ||
| Preferred stock-Series DConvertible Preferred Stock | 0 | - | ||
| Common stock 0.001 par value 70,000,000 shares authorized 11,648,323 and 8,873,932 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 12 | 9 | ||
| Additional paid-in capital | 130,992 | 122,259 | ||
| Accumulated deficit | -133,585 | -126,936 | ||
| Total stockholders (deficit) equity | -2,581 | -4,668 | ||
| Total liabilities and stockholders equity | 15,415 | 20,142 | ||
Biofrontera Inc. (BFRI)
Biofrontera Inc. (BFRI)